| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
532.30 |
106.46 |
638.76 |
4% |
10.00 |
542.30 |
108.46 |
650.76 |
16% |
25.00 |
567.30 |
113.46 |
680.76 |
промяна в обстоятелствата НСР-6995/24.08.2015; НСР-16382/02.08.2018 |
НСР-5519/29.01.2015; НСР-15279/22.03.2018 (предварително изпълнение); НСР-17799/24.01.2019 |
02.03.2019 |
02.03.2019 |
Заличен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
532.30 |
106.46 |
638.76 |
4% |
10.00 |
542.30 |
108.46 |
650.76 |
16% |
25.00 |
567.30 |
113.46 |
680.76 |
промяна в обстоятелствата НСР-6995/24.08.2015; НСР-16382/02.08.2018 |
НСР-5519/29.01.2015; НСР-15279/22.03.2018 (предварително изпълнение) |
22.03.2018 |
02.09.2018 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
532.30 |
106.46 |
638.76 |
4% |
10.00 |
542.30 |
108.46 |
650.76 |
16% |
25.00 |
567.30 |
113.46 |
680.76 |
промяна в обстоятелствата НСР-6995/24.08.2015 |
НСР-5519/29.01.2015; НСР-15279/22.03.2018 (предварително изпълнение) |
22.03.2018 |
02.04.2018 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
569.05 |
113.81 |
682.86 |
4% |
10.00 |
579.05 |
115.81 |
694.86 |
16% |
25.00 |
604.05 |
120.81 |
724.86 |
промяна в обстоятелствата НСР-6995/24.08.2015 |
НСР-5519/29.01.2015 |
12.02.2015 |
12.02.2015 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
577.48 |
115.50 |
692.98 |
4% |
10.00 |
587.48 |
117.50 |
704.98 |
16% |
25.00 |
612.48 |
122.50 |
734.98 |
|
НСР-3731/06.06.2014 |
23.06.2014 |
23.06.2014 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
584.32 |
116.86 |
701.18 |
4% |
10.00 |
594.32 |
118.86 |
713.18 |
16% |
25.00 |
619.32 |
123.86 |
743.18 |
|
НСР-1432/10.10.2013 |
25.10.2013 |
25.10.2013 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
619.06 |
123.81 |
742.87 |
4% |
10.00 |
629.06 |
125.81 |
754.87 |
16% |
25.00 |
654.06 |
130.81 |
784.87 |
|
КЦРР-922/04.07.2012 |
19.07.2012 |
19.07.2012 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
683.58 |
136.72 |
820.30 |
6% |
15.00 |
698.58 |
139.72 |
838.30 |
18% |
30.00 |
728.58 |
145.72 |
874.30 |
|
КЦ-531/19.02.2009 |
13.03.2009 |
13.03.2009 |
Неактивен |
3539 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
33.95 |
6.79 |
40.74 |
4% |
1.36 |
35.31 |
7.06 |
42.37 |
16% |
5.43 |
40.74 |
8.15 |
48.89 |
|
НСР-8564/24.03.2016.; НСР-12178/27.03.2017 |
08.04.2016 |
02.05.2017 |
Заличен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
33.95 |
6.79 |
40.74 |
4% |
1.36 |
35.31 |
7.06 |
42.37 |
16% |
5.43 |
40.74 |
8.15 |
48.89 |
|
НСР-8564/24.03.2016. |
08.04.2016 |
08.04.2016 |
Неактивен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 100 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
16.98 |
3.40 |
20.38 |
6% |
1.02 |
18.00 |
3.60 |
21.60 |
18% |
3.06 |
21.06 |
4.21 |
25.27 |
|
НСР-8563/24.03.2016. |
08.04.2016 |
08.04.2016 |
Активен |
386 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
61.39 |
12.28 |
73.67 |
4% |
2.46 |
63.85 |
12.77 |
76.62 |
16% |
9.82 |
73.67 |
14.73 |
88.40 |
промяна в обстоятелствата КЦPP-2270/11.02.2013 |
КЦ-390/07.01.2009 |
04.02.2009 |
04.02.2009 |
Неактивен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 100 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
32.41 |
6.48 |
38.89 |
4% |
1.30 |
33.71 |
6.74 |
40.45 |
16% |
5.19 |
38.90 |
7.78 |
46.68 |
промяна в обстоятелствата КЦPP-2270/11.02.2013 |
КЦ-390/07.01.2009 |
04.02.2009 |
04.02.2009 |
Неактивен |
386 |
| Aripiprazole |
20150245 |
Explemed, Tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLCH-1165 Budapest, Bökényföldiút 118-120.Унгария |
60.53 |
12.11 |
72.64 |
4% |
2.42 |
62.95 |
12.59 |
75.54 |
16% |
9.68 |
72.63 |
14.53 |
87.16 |
|
НСР-7029/25.08.2015; НСР-11086/01.12.2016 г. |
17.12.2016 |
02.01.2017 |
Активен |
4067 |
| Aripiprazole |
20150245 |
Explemed, Tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLCH-1165 Budapest, Bökényföldiút 118-120.Унгария |
84.75 |
16.95 |
101.70 |
4% |
3.39 |
88.14 |
17.63 |
105.77 |
16% |
13.56 |
101.70 |
20.34 |
122.04 |
|
НСР-7029/25.08.2015 |
09.09.2015 |
09.09.2015 |
Неактивен |
4067 |
| Aripiprazole |
20150226 |
Explemed Rapid, Orodispersible tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, H-1165 Budapest, Bökényföldi út 118-120, Унгария |
58.71 |
11.74 |
70.45 |
4% |
2.35 |
61.06 |
12.21 |
73.27 |
16% |
9.39 |
70.45 |
14.09 |
84.54 |
|
НСР-7031/25.08.2015; НСР-10851/10.11.2016; НСР-15167/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
4066 |
| Aripiprazole |
20150226 |
Explemed Rapid, Orodispersible tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, H-1165 Budapest, Bökényföldi út 118-120, Унгария |
82.81 |
16.56 |
99.37 |
4% |
3.31 |
86.12 |
17.22 |
103.34 |
16% |
13.25 |
99.37 |
19.87 |
119.24 |
|
НСР-7031/25.08.2015; НСР-10851/10.11.2016 |
26.11.2016 |
02.12.2016 |
Неактивен |
4066 |
| Aripiprazole |
20150226 |
Explemed Rapid, Orodispersible tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, H-1165 Budapest, Bökényföldi út 118-120, Унгария |
84.75 |
16.95 |
101.70 |
4% |
3.39 |
88.14 |
17.63 |
105.77 |
16% |
13.56 |
101.70 |
20.34 |
122.04 |
|
НСР-7031/25.08.2015 |
09.09.2015 |
09.09.2015 |
Неактивен |
4066 |
| Interferon beta-1b |
ЕU/1/08/454/008 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Germany |
907.19 |
181.44 |
1088.63 |
4% |
10.00 |
917.19 |
183.44 |
1100.63 |
16% |
25.00 |
942.19 |
188.44 |
1130.63 |
Промяна на обстоятелствата НСР-16305/27.07.2018. |
НСР-7473/12.11.2015; НСР-14793/10.01.2018 |
25.01.2018 |
02.09.2018 |
Активен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
907.19 |
181.44 |
1088.63 |
4% |
10.00 |
917.19 |
183.44 |
1100.63 |
16% |
25.00 |
942.19 |
188.44 |
1130.63 |
|
НСР-7473/12.11.2015; НСР-14793/10.01.2018 |
25.01.2018 |
02.02.2018 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
907.19 |
181.44 |
1088.63 |
4% |
10.00 |
917.19 |
183.44 |
1100.63 |
16% |
25.00 |
942.19 |
188.44 |
1130.63 |
|
НСР-7473/12.11.2015; НСР-14793/10.01.2018 |
25.01.2018 |
02.02.2018 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
981.81 |
196.36 |
1178.17 |
4% |
10.00 |
991.81 |
198.36 |
1190.17 |
16% |
25.00 |
1016.81 |
203.36 |
1220.17 |
|
НСР-7473/12.11.2015 |
27.11.2015 |
27.11.2015 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
1027.26 |
205.45 |
1232.71 |
4% |
10.00 |
1037.26 |
207.45 |
1244.71 |
16% |
25.00 |
1062.26 |
212.45 |
1274.71 |
|
НСР-4537/22.08.2014 |
08.09.2014 |
08.09.2014 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
1257.27 |
251.45 |
1508.72 |
4% |
10.00 |
1267.27 |
253.45 |
1520.72 |
16% |
25.00 |
1292.27 |
258.45 |
1550.72 |
промяна на обстоятелства НСР-4521/22.08.2014 ( в сила от 08.09.2014) |
НСР-1733/21.11.2013 |
09.12.2013 |
09.12.2013 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharmaceuticals UK Limited, Обединеното кралство |
1259.53 |
251.91 |
1511.44 |
4% |
10.00 |
1269.53 |
253.91 |
1523.44 |
16% |
25.00 |
1294.53 |
258.91 |
1553.44 |
|
КЦРР-2188/06.02.2013 г |
25.02.2013 |
25.02.2013 |
Неактивен |
3155 |